William Woods
Stock Analyst at B. Riley Securities
(1.05)
# 3,881
Out of 5,117 analysts
11
Total ratings
50%
Success rate
-10.82%
Average return
Main Sectors:
Stocks Rated by William Woods
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $560 → $670 | $598.91 | +11.87% | 1 | Dec 11, 2025 | |
| OKYO OKYO Pharma | Initiates: Buy | $5 | $1.99 | +151.26% | 1 | Dec 8, 2025 | |
| CGTX Cognition Therapeutics | Reiterates: Buy | $2 → $3 | $1.45 | +106.90% | 1 | Nov 21, 2025 | |
| LFMD LifeMD | Maintains: Buy | $12 → $10 | $3.50 | +185.71% | 3 | Nov 18, 2025 | |
| IMUX Immunic | Reiterates: Buy | $6 → $5 | $0.56 | +790.79% | 3 | May 23, 2025 | |
| VERU Veru Inc. | Initiates: Buy | $50 | $2.40 | +1,983.33% | 1 | May 14, 2024 | |
| KRMD KORU Medical Systems | Reiterates: Buy | $4 | $6.23 | -35.79% | 1 | Mar 14, 2024 |
Madrigal Pharmaceuticals
Dec 11, 2025
Maintains: Buy
Price Target: $560 → $670
Current: $598.91
Upside: +11.87%
OKYO Pharma
Dec 8, 2025
Initiates: Buy
Price Target: $5
Current: $1.99
Upside: +151.26%
Cognition Therapeutics
Nov 21, 2025
Reiterates: Buy
Price Target: $2 → $3
Current: $1.45
Upside: +106.90%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $3.50
Upside: +185.71%
Immunic
May 23, 2025
Reiterates: Buy
Price Target: $6 → $5
Current: $0.56
Upside: +790.79%
Veru Inc.
May 14, 2024
Initiates: Buy
Price Target: $50
Current: $2.40
Upside: +1,983.33%
KORU Medical Systems
Mar 14, 2024
Reiterates: Buy
Price Target: $4
Current: $6.23
Upside: -35.79%